SCHEMBL13005289

SCHEMBL13005289

CCOC(=O)/C(=C/c1cccc(Br)c1)CC(=O)O

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 5/20 0.49
MEN1 O00255 3/20 0.49
KMT2A Q03164 3/20 0.49
MAPK1 P28482 2/20 0.49
NPSR1 Q6W5P4 2/20 0.49
S1PR4 O95977 1/20 0.49
LMNA P02545 1/20 0.49
S1PR1 P21453 1/20 0.49
RECQL P46063 1/20 0.46
SLC6A19 Q695T7 1/20 0.45
PTGS2 P35354 3/20 0.45
CYP19A1 P11511 1/20 0.44
PDCD1 Q15116 1/20 0.43
CD274 Q9NZQ7 1/20 0.43
EPHX2 P34913 1/20 0.43
ALDH1A1 P00352 3/20 0.43
KDM4E B2RXH2 1/20 0.42
SMN1; SMN2 Q16637 1/20 0.42
GAA P10253 1/20 0.42
GLO1 Q04760 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18961296 0.91 KMT2A (0.50) MAPTMEN1KMT2AMAPK1NPSR1
SCHEMBL13379257 0.88 KMT2A (0.52) MAPTMEN1KMT2AMAPK1NPSR1
SCHEMBL25410057 0.86 KMT2A (0.51) MAPTMEN1KMT2AMAPK1NPSR1
SCHEMBL7300688 0.84 MEN1 (0.68) MAPTMEN1KMT2AMAPK1NPSR1
SCHEMBL7300691 0.84 MEN1 (0.68) MAPTMEN1KMT2AMAPK1NPSR1
SCHEMBL1676278 0.83 KMT2A (0.54) MAPTMEN1KMT2AMAPK1NPSR1
SCHEMBL6232140 0.83 MAPT (0.50) MAPTMEN1KMT2ALMNARECQL
SCHEMBL6232135 0.83 MAPT (0.50) MAPTMEN1KMT2ALMNARECQL
SCHEMBL6232132 0.83 MAPT (0.50) MAPTMEN1KMT2ALMNARECQL
SCHEMBL28471290 0.82 KMT2A (0.55) MAPTMEN1KMT2AMAPK1NPSR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9102652-B2 Dichroic-photochromic 2H-naphtho[1,2-b]pyran compounds and devices ALPHAMICRON INCORPORATED (US) 2015-08-11 US disclosed
US-9102652-B2 Dichroic-photochromic 2H-naphtho[1,2-b]pyran compounds and devices ALPHAMICRON INCORPORATED (US) 2015-08-11 US disclosed
US-20140197361-A1 DICHROIC-PHOTOCHROMIC 2H-NAPHTHO[1,2-b]PYRAN COMPOUNDS AND DEVICES ALPHAMICRON INCORPORATED (US) 2014-07-17 US disclosed
US-20140197361-A1 DICHROIC-PHOTOCHROMIC 2H-NAPHTHO[1,2-b]PYRAN COMPOUNDS AND DEVICES ALPHAMICRON INCORPORATED (US) 2014-07-17 US disclosed
EP-2076504-B1 DICHROIC-PHOTOCHROMIC COMPOUNDS AND DEVICES ALPHAMICRON INC (US) 2014-05-14 EP disclosed
US-20100324296-A1 DICHROIC-PHOTOCHROMIC COMPOUNDS AND DEVICES ALPHAMICRON INCORPORATED 2010-12-23 US disclosed
US-20100324296-A1 DICHROIC-PHOTOCHROMIC COMPOUNDS AND DEVICES ALPHAMICRON INCORPORATED 2010-12-23 US disclosed
WO-2008051420-A2 DICHROIC-PHOTOCHROMIC COMPOUNDS AND DEVICES ALPHAMICRON, INC. (US) 2008-05-02 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20140197361-A1 DICHROIC-PHOTOCHROMIC 2H-NAPHTHO[1,2-b]PYRAN COMPOUNDS AND DEVICES NR0B2, NR0B1, DHCR24 MAPT 4116/4885MEN1 3414/4885KMT2A 1590/4885
US-20100324296-A1 DICHROIC-PHOTOCHROMIC COMPOUNDS AND DEVICES NR0B2, NR0B1, NR2E3 MAPT 3651/4885MEN1 3404/4885KMT2A 1578/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.